Addex Therapeutics Ltd ADXN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.21M | -2.18M | -2.30M | -1.97M | -1.64M |
| Total Depreciation and Amortization | 31.90K | 12.50K | 2.70K | 2.60K | 2.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.37M | 1.60M | 1.33M | 1.12M | 989.40K |
| Change in Net Operating Assets | 218.00K | -402.50K | 194.90K | 179.30K | -19.40K |
| Cash from Operations | -592.70K | -977.00K | -775.30K | -666.50K | -666.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -4.30K | 75.10K | -- |
| Cash from Investing | -- | -- | -4.30K | 75.10K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -32.70K | -1.60K | -1.90K | -1.80K | -1.80K |
| Issuance of Common Stock | 338.10K | 73.50K | 85.00K | 366.20K | -- |
| Repurchase of Common Stock | -15.70K | -3.20K | -6.50K | -2.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -3.40K | -1.00K | -600.00 | 99.80K |
| Cash from Financing | 366.70K | 83.50K | 94.70K | 451.30K | 109.00K |
| Foreign Exchange rate Adjustments | 13.60K | -3.90K | -1.90K | -2.10K | -17.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -212.40K | -897.50K | -686.70K | -142.20K | -574.30K |